Читать книгу De PhD y otros demonios - Sandra Bermeo - Страница 74

1. Nozais JP. The origen and dispersión of human parasitic diseases in the Old World (Africa, Europe and Madagascar). Mem Inst Oswaldo Cruz 2003; 98 Suppl 1:13-9.

2. Gerabek WE. The tooth worm: historical aspects of a popular medical belief. Clin Oral Investig. 1999 Mar;3(1):1-6.

3. Schmidt GD, Roberts LS. Foundations of Parasitology. 2ª ed. London: CV Mosby Co; 1981.

4. Bruschi F, Masetti M, Locci MT, Ciranni R, Fornaciari G. Short report: cysticercosis in an Egyptian mummy of the late Ptolemaic period. Am J Trop Med Hyg. 2006;74(4):598-9.

5. Levítico 11:4-8. Biblia.

6. Blancou J. History of trichinellosis surveillance. Parasite. 2001 Jun;8(2 Suppl):S16-9.

7. Casadevall A, Pirofski LA. Host-Pathogen Interactions: basic concepts of microbial commensalism, colonization, infection, and disease. Infect Immun. 2000 Dec;68(12):6511-8.

8. Hickman C, Roberts R, Larson A, I’Anson H, Eisenhour D. Clasificación y filogenia de los animales. En: Pardos F, editor. Principios integrales de Zoología. 13ª ed. Madrid: McGraw-Hill Interamericana; 2006. p. 921.

9. Woose CR, Kandler O, Wheelis ML. Towards a natural system of organisms: proposal for the domains Archaea, Bacteria and Eucarya. Proc Natl Acad Sci U S A. 1990 Jun;87(12):4576-9.

10. Kassai T, Cordero del Campillo M, Euzeby J, Gaafar S, Hiepe T, Himonas CA. Standardized nomenclature of animal parasitic diseases (SNOAPAD). Vet Parasitol. 1988 Oct;29(4):299-326.

11. Gensini GF, Conti AA, Lippi D. The contributions of Paul Ehrlich to infectious diseases. J Infect. 2007 Mar;54(3):221-4.

12. Garnham PCC, Pierce AE, Roitt I. Immunity to Protozoa. a symposium of the British Society for Immunology. Oxford: Blacwell Scientific Pub.; 1963. p. 359.

13. Taliaferro WH. Host resistance and types of infection in tripanosomiasis and malaria. Qualt Rev Biol. 1926; 1(2):246-69.

14. Alpers S, Laws R, Lackford B, Boyd WA, Dunlap P, Freedman JH, et al. Identification of innate immunity genes and pathways using a comparative genomic approach. Proc Natl Acad Sci U S A. 2008 May 13;105(19):7016-21.

15. Plant JE, Blackwell JM, O´Brien AD, Bradley DJ, Glynn AA. Are the Lsh and Ity disease resistance genes at one locus on Mouse chromosome 1? 1982 Jun 10;297(5866):510-1.

16. Horn D. The molecular control of antigenic variation in Trypanosome brucei. Curr Mol Med 2004 Sep;4(6):563-76.

17. McLaren DJ. Disguise as an evasive stratagem of parasitic organisms. Parasitology. 1984 Aug; 88 (Pt 4):597-611.

18. Schmidt J. Glycans with N-acetyllactosamine type 2-like residues covering adult Schistosoma mansoni, and glycomimesis as a putative mechanism of immune evasion. Parasitology. 1995 Sep; 111 (Pt 3):325-36.

19. Riley EM, Jobe O, Whittle HC. CD8+ T cells inhibit Plasmodium falciparum -induced lymphoproliferation and gamma interferon production in cell preparations from some malaria-immune individuals. Infect Immun. 1989 Apr;57(4):1281-4.

20. Dermine JF, Goyette G, Houde M, Turco SJ, Desjardins M. Leishmania donovani lipophosphoglycan disrupts phagosome microdomains in J774 macrophages. Cell Microbiol. 2005 Sep;7(9):1263-70.

21. Ota H, Takashima Y, Matsumoto Y, Hayashi Y, Masumoto Y. Pretreatment of macrophages with the combination of IFN-gamma and IL-12 induces resistance to Leishmania major at the early phase of infection. J Vet Med Sci. 2008 Jun;70(6):589-93.

22. Del Prete G, Maggi E, Romagnani S. Human Th1 and Th2 cells: Functional Properties, mechanisms of regulation, and role in disease. Lab Invest. 1994 Mar;70(3):299-306.

23. Fenton A, Lamb T, Graham AL. Optimality análisis of Th1/Th2 immune responses during microparasite-macroparasite co-infection, with epidemiological feedbacks. Parasitology. 2008 Jun;135(7):841-53.

24. Negrão-Corrêa D. Imporance of immunoglobulin E (IgE) in the protective mechanism against gastrointestinal nematode infection: looking at the intestinal mucosae. Rev Inst Med Trop Sao Paulo. 2001 Sep-Oct;43(5):291-9.

25. Liesenfeld O, Dunay IR, Erb KJ. Infection with Toxoplasma gondii reduces established and developing Th2 responses induced by Nippostrongylus braziliensis infection. Infect Immun. 2004 Jul;72(7):3812-22.

26. Cooper PJ, Ayre G, Martin C, Rizzo JA, Ponte EV, Cruz AA. Geohelminth infections: a review of the role of IgE and assessment of potential risks of anti-IgE treatment. Allergy. 2008 Apr;63(4):409-17.

27. MacDonald AS, Araujo MI, Pearce EJ. Immunology of parasitic helminth infections. Infect Immun. 2002 Feb;70(2):427-33.

28. Castro GA. Immunophysiology of enteric parasitism. Parasitol Today. 1989; 5(1):11-9.

29. Okerengo AA, Adeniyi A, Williams AI, Osunkoya O. Studies on the immunopathology of the nephritic syndrome associated with Plasmodium malariae. 1. Serum levels of an immune adherence inhibitor. Afr J Med Med Sci. 1980 Mar-Jun;9(1-2):43-7.

30. Holmes PH. Pathophysiology of parasitic infections. Parasitology. Parasitology. 1987;94 Suppl:S29-51.

31. Thompson PE, Graedel SK, Schneider CR, Stucki WB, Gordon RM. Preparation and evaluation of standardized amoeba antigen from axenic cultures of Entamoeba histolytica. Bull World Health Organ. 1968;39(3):349-65.

32. Diamond LS, Clark CG. A redescription of Entamoeba histolytica Schaudinn, 1903 (Emended Walker 1911) separating it from Entamoeba dispar Brumpt, 1925. J Eukaryot Microbiol. 1993 May-Jun;40(3):340-4.

33. García-Agudo L, Rodríguez-Iglesias M. [ELISA test for the detection of Entamoeba histolytica in stool specimens]. Enferm Infecc Microbiol Clin. 2007 Dec;25(10):657.

34. Donelson JE. Antigenic variation and the African trypanosome genome. Acta Trop. 2003 Mar;85(3):391-404.

35. Miller TA. Vaccination against the canine hookworm diseases. Adv Parasitol. 1971;9:153-83.

36. Drew DR, Lightowlers M, Strugnell RA. Humoral immune responses to DNA vaccines expressing secreted, membrane bound and non-secreted forms of the Taenia ovis 45W antigen. Vaccine. 2000 May 22;18(23):2522-32.

37. Molinari JL, Soto R, Tato P, Rodriguez D, Retana A, Sepúlveda J, et al. Immunization against porcine cysticercosis in an endemic area in Mexico: a field and laboratory study. Am J Trop Med Hyg. 1993 Oct;49(4):502-12.

38. Weis JB. DNA probes and PCR for diagnosis of parasitic infection. Clin Microbiol Rev. 1995 Jan;8(1):113-30.

39. Barker DC. Molecular approaches to DNA diagnosis. Parasitology. 1989;99 Suppl:S125-46.

40. Botero D. Persistencia de las parasitosis intestinales endémicas en América Latina. Bol Of Sanit Panam. 1981; 90(1):39-47.

41. Hotez PJ. Global Christianity and the control of its neglected tropical diseases. PLoS Negl Trop Dis. 2014 Nov 20;8(11):e3135.

42. Apt W. Helmintiasis intestinales humanas en América Latina. Prevalencia actual y sus factores contribuyentes. Parasitol al día 1987; 11:155-166.

43. Galán R, Agualimpia C, Corredor-Arjona A, Cáceres-Vega E. Parasitismo Intestinal. Estudio de recursos humanos para la salud y educación médica en Colombia. Ministerio de Salud. Asociación de Facultades de Medicina. 1969.

44. Corredor A, Arciniegas E, Hernández CA. Parasitismo Intestinal. Bogotá: Ministerio de Salud, Instituto Nacional de Salud. Colombia. 2002.

45. CE, López MC, Reyes P, Gómez JE, Corredor A, Agudelo C. Diferenciación de Entamoeba histolytica y Entamoeba dispar en muestras de materia fecal por detección de adhesina de E. histolytica mediante ELISA. Biomédica. 2001; 21(2):167-71.

46. WHO-UNICEF. World Malaria Report. En: WHO [en línea] 2005 [consultado en el 2005]. Disponible en:

47. Guhl F, Lazdins-Helds J. Reporte sobre la enfermedad de Chagas. Reporte del grupo de trabajo científico sobre la enfermedad de Chagas. 17-20 de abril de 2005. Buenos Aires, Argentina: OMS/TDR; 2007.

48. Padilla JC. Situación de la enfermedad de Chagas en Colombia. En: Guhl F, editor. Memorias del primer taller internacional sobre control de la enfermedad de Chagas. Bogotá: Universidad de los Andes. Colombia; 2005. p. 19-24.

49. Parra GJ, Restrepo M, Restrepo BN, Domínguez J. Estudio de tripanosomiasis americana en dos poblados indígenas de la Sierra Nevada de Santa Marta. Revista CES Medicina. 2004; 18(1):43-50.

50. Restrepo, M, Parra, GJ, Restrepo C. Morbilidad de la enfermedad de Chagas en la Sierra Nevada de Santa Marta. En: Guhl F, Jaramillo CA, editores. Curso Taller Internacional – Sistemas de Información Geográfica, Sensores Remotos y Genética Poblacional de Vectores y Parásitos aplicados al control de la enfermedad de Chagas. Bogotá: Universidad de los Andes. 2002; p. 121-4.

51. Montresor A, Gyorkos TW, Crompton DWT, Bundy DAP, Savioli L. Monitoreo de los programas de control de helmintiasis. Washington D.C: OPS/HCP/ HCT/P/177/01. 2001.

52. Savioli L, Stansfield S, Bundy DA, Mitchell A, Bhatia R, Engels D et al. Schistosomiasis and soil-transmitted helminth infections: forging control efforts. Trans R Soc Trop Med Hyg. 2002 Nov-Dec;96(6):577-9.

53. WHO/Department of Communicable Disease Prevention, Control and Eradication. Prevention and control of schistosomiasis and soil-transmitted helminthiasis: WHO Technical Report Series N° 912. Ginebra; 2002.

54. Zani LC, Favre TC, Pieri OS, Barbosa CS. Impact of antihelminthic treatment on infection by Ascaris lumbricoides, Trichuris trichiura and hookworms in Covas, a rural community of Pernambuco, Brazil. Rev Inst Med Trop Sao Paulo. 2004 Mar-Apr;46(2):63-71.